MALAT1 Promotes the Proliferation and Invasion of Thyroid Cancer Cells Via Regulating the Expression of IQGAP1
Overview
General Medicine
Pharmacology
Authors
Affiliations
Background: Increasing evidence indicated that metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) acted as a key regulator in the proliferation and invasion of several cancers. However, the function of MALAT1 in the development of thyroid cancer has not been experimentally established.
Methods: The expression of MALAT1 and IQGAP1 in thyroid cancer tissues and cells were detected by quantitative real-time PCR and western blot. The effects of MALAT1 and IQGAP1 on the cell proliferation and invasion of thyroid cancer cells were detected with a 3-(4,5-dimethylthiazol)-2,5-diphenyl tetrazolium 4 (MTT) assay and a Transwell assay, respectively. FTC-133 or SW1736 transfected with si-MALAT1 or pcDNA-MALAT1 were injected subcutaneously into 4-week-olds BALB/c mice to examine the impact of MALAT1 on the tumor development of thyroid cancer in vivo.
Results: In this study, we discovered the higher level of MALAT-1 and expression of IQGAP1 in thyroid cancer tissues and in thyroid cancer cells compared to that in the control. MTT and Transwell assay showed that the proliferation and invasion of FTC-133 cells with MALAT-1 knockdown were inhibited. Moreover, MALAT-1 could upregulate the expression of IQGAP1 in thyroid cancer cells. In addition, IQGAP1 knockdown reversed the decreasing cell proliferation and invasion of thyroid cancer induced by MALAT-1 overexpression. Finally, the study in vivo verified that MALAT-1 promoted the tumor growth of thyroid cancer.
Conclusion: Our study indicated that MALAT1 promoted the proliferation and invasion of thyroid cancer cells via regulating the expression of IQGAP1.
Sayed N, Shaker O, Abd-Elmawla M, Gamal A, Fathy N Clin Rheumatol. 2025; 44(2):775-787.
PMID: 39798064 PMC: 11774967. DOI: 10.1007/s10067-024-07291-x.
Sabi E Front Oncol. 2024; 14:1474267.
PMID: 39558949 PMC: 11570407. DOI: 10.3389/fonc.2024.1474267.
Song M, Sun W, Liu Q, Wang Z, Zhang H Front Endocrinol (Lausanne). 2024; 14:1306232.
PMID: 38298184 PMC: 10829784. DOI: 10.3389/fendo.2023.1306232.
Liu S, Li F, Deng L, Ma Q, Lu W, Zhao Z Mol Ther Oncolytics. 2023; 30:275-285.
PMID: 37701851 PMC: 10493249. DOI: 10.1016/j.omto.2023.08.011.
Mahdiannasser M, Khazaei S, Akhavan Rahnama M, Soufi-Zomorrod M, Soutodeh F, Parichehreh-Dizaji S Noncoding RNA Res. 2023; 8(3):451-458.
PMID: 37455764 PMC: 10339060. DOI: 10.1016/j.ncrna.2023.05.006.